Package 65162-449-03

Brand: entecavir

Generic: entecavir
NDC Package

Package Facts

Identity

Package NDC 65162-449-03
Digits Only 6516244903
Product NDC 65162-449
Product ID 65162-449_c0f7f2de-7a13-4703-9569-262ea1f20cff
Description

30 TABLET, FILM COATED in 1 BOTTLE (65162-449-03)

Marketing

Marketing Status
Marketed Since 2014-11-28
Brand entecavir
Generic entecavir
Sample Package No

Linked Drug Pages (1)

Entecavir ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "c0f7f2de-7a13-4703-9569-262ea1f20cff", "openfda": {"upc": ["0365162446036", "0365162449037"], "unii": ["5968Y6H45M"], "rxcui": ["485434", "485436"], "spl_set_id": ["007a6ad8-4d23-4543-ae48-c651cac7dd7b"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (65162-449-03)", "package_ndc": "65162-449-03", "marketing_start_date": "20141128"}], "brand_name": "Entecavir", "product_id": "65162-449_c0f7f2de-7a13-4703-9569-262ea1f20cff", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Analog [EXT]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "65162-449", "generic_name": "Entecavir", "labeler_name": "Amneal Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Entecavir", "active_ingredients": [{"name": "ENTECAVIR", "strength": "1 mg/1"}], "application_number": "ANDA206652", "marketing_category": "ANDA", "marketing_start_date": "20141128", "listing_expiration_date": "20261231"}